Usefulness and safety of 0.4% sodium hyaluronate solution as a submucosal fluid "cushion" in endoscopic resection for gastric neoplasms: a prospective multicenter trial
- PMID: 18155216
- DOI: 10.1016/j.gie.2007.07.039
Usefulness and safety of 0.4% sodium hyaluronate solution as a submucosal fluid "cushion" in endoscopic resection for gastric neoplasms: a prospective multicenter trial
Abstract
Background: Sodium hyaluronate (SH) solution has been used for submucosal injection in endoscopic resection to create a long-lasting submucosal fluid "cushion."
Objectives: Our purpose was to assess the usefulness and safety of 0.4% SH solution in endoscopic resection.
Design: A prospective multicenter randomized controlled trial.
Setting: Six referral hospitals in Japan.
Patients: One hundred forty patients with 5- to 20-mm gastric intramucosal neoplastic lesions.
Interventions: Patients were randomized into 0.4% SH and control groups. Endoscopic resection was performed with 0.4% SH or normal saline solution for submucosal injection.
Primary outcome measure: The usefulness of 0.4% SH solution was assessed by en bloc complete resection and the formation and maintenance of mucosal lesion-lifting during endoscopic resection.
Secondary outcome measures: (1) steepness of mucosal lesion lifting, (2) complications, (3) time required for mucosal resection, (4) volume of submucosal injection solution, and (5) ease of mucosal resection. Safety was assessed by analyzing adverse events during the study period.
Results: The usefulness rate was significantly higher for the 0.4% SH group (88.4%, 61/69) than for the control group (58.6%, 41/70). As secondary outcome measures, significant intergroup differences (P < .001) were noted for (1) steepness of mucosal lesion lifting, (2) volume of submucosal injection solution, and (3) ease of mucosal resection. No serious adverse events were encountered in either group.
Limitations: Lack of blinding. Safety was not a powered outcome measure.
Conclusions: Using 0.4% SH as a submucosal injection solution in endoscopic resection enabled the formation and maintenance of sufficient mucosal lesion lifting for gastric intramucosal lesions, reducing the need for additional injections and simplifying mucosal resection. Use of 0.4% SH thus simplifies the complicated procedures involved in endoscopic resection.
Comment in
-
Submucosal fluid cushion and EMR: who rules the roost?Gastrointest Endosc. 2008 May;67(6):840-2. doi: 10.1016/j.gie.2007.11.047. Gastrointest Endosc. 2008. PMID: 18440376 No abstract available.
Similar articles
-
Usefulness and safety of 0.4% sodium hyaluronate solution as a submucosal fluid "cushion" for endoscopic resection of colorectal mucosal neoplasms: a prospective multi-center open-label trial.BMC Gastroenterol. 2009 Jan 8;9:1. doi: 10.1186/1471-230X-9-1. BMC Gastroenterol. 2009. PMID: 19128517 Free PMC article. Clinical Trial.
-
Success rate of curative endoscopic mucosal resection with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate.Gastrointest Endosc. 2002 Oct;56(4):507-12. doi: 10.1067/mge.2002.128108. Gastrointest Endosc. 2002. PMID: 12297765
-
Efficacy and safety of 0.4 percent sodium hyaluronate for endoscopic submucosal dissection of gastric neoplasms.World J Gastroenterol. 2013 May 28;19(20):3069-76. doi: 10.3748/wjg.v19.i20.3069. World J Gastroenterol. 2013. PMID: 23716986 Free PMC article. Clinical Trial.
-
Endoscopic submucosal dissection of early gastric cancer.Digestion. 2008;77 Suppl 1:23-8. doi: 10.1159/000111484. Epub 2008 Jan 18. Digestion. 2008. PMID: 18204258 Review.
-
Solutions for submucosal injection: What to choose and how to do it.World J Gastroenterol. 2019 Feb 21;25(7):777-788. doi: 10.3748/wjg.v25.i7.777. World J Gastroenterol. 2019. PMID: 30809079 Free PMC article. Review.
Cited by
-
Short- and long-term outcomes of endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy.J Gastroenterol. 2019 Jun;54(6):511-520. doi: 10.1007/s00535-018-1528-1. Epub 2018 Nov 9. J Gastroenterol. 2019. PMID: 30413872
-
Endoscopic Management of Complex Colorectal Polyps: Current Insights and Future Trends.Front Med (Lausanne). 2022 Jan 20;8:728704. doi: 10.3389/fmed.2021.728704. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35127735 Free PMC article. Review.
-
Submucosal Injection Solutions for ESD: Separating the Winners from the Losers.Dig Dis Sci. 2019 Oct;64(10):2699-2700. doi: 10.1007/s10620-019-05743-y. Dig Dis Sci. 2019. PMID: 31363953 No abstract available.
-
Utility and performance characteristics of a novel submucosal injection agent (EleviewTM) for endoscopic mucosal resection and endoscopic submucosal dissection.Transl Gastroenterol Hepatol. 2018 Jun 19;3:32. doi: 10.21037/tgh.2018.06.01. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30050992 Free PMC article.
-
Endoscopic full-thickness resection of a lateral spreading rectal tumor after unplanned injection of dilute hyaluronic acid into the subserosal layer (with video).Tech Coloproctol. 2012 Jun;16(3):247-50. doi: 10.1007/s10151-012-0811-z. Epub 2012 Feb 21. Tech Coloproctol. 2012. PMID: 22350267
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials